Treatment of low-grade intermediate-risk non-muscle invasive bladder cancer with UGN-102: Results of the phase 3 ATLAS and ENVISION studies.

Authors: Sandip M. Prasad, Marc Bjurlin, Dimitar Shishkov, Nikola V. Mihaylov, Alexandre Khuskivadze, Pencho Genov, Vasyl Terzi, Max Kates, Willliam C. Huang, Michael J. Louie, Sunil Raju, Brent Burger, Andrew Meads, Brian Hu,

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16595

Source: Full article

---

Abstract

e16595